Tratamiento de la hipertensión severa en el embarazo

1. Rey E, LeLorier J, Burgess E, Lange IR, Leduc L. Report of the Canadian Hypertension Society Consensus Conference: 3. Pharmacologic treatment of hypertensive disorders in pregnancy. CMAJ 1997;157: 1245-54.[Abstract]
2. Department of Health. Report on confidential enquiries into maternal deaths in England and Wales 1982-1984. London: HMSO, 1989.
3. Department of Health. Report on confidential enquiries into maternal deaths in the United Kingdom 1985-1987. London: HMSO, 1991.
4. Department of Health. Report on confidential enquiries into maternal deaths in the United Kingdom 1988-1990. London: HMSO, 1994.
5. Department of Health. Report on confidential enquiries into maternal deaths in the United Kingdom 1991-1993. London: HMSO, 1996.
6. Lewis G, Drife J, eds. Why mothers die 1997-1999. The confidential enquiries into maternal deaths in the UK. London: RCOG Press, 2001.
7. Report of the National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy. Am J Obstet Gynecol 2000;183: S1-22.[CrossRef][ISI]
8. Brown MA, Hague WM, Higgins J, Lowe S, McCowan L, Oats J, et al. The detection, investigation and management of hypertension in pregnancy: executive summary. Aust N Z J Obstet Gynaecol 2000;40: 133-8.[ISI][Medline]
9. Impey L. Severe hypotension and fetal distress following sublingual administration of nifedipine to a patient with severe pregnancy induced hypertension at 33 weeks. Br J Obstet Gynaecol 1993;100: 959-61.[ISI][Medline]
10. Olsen KS, Beier-Holgersen R. Fetal death following labetalol administration in pre-eclampsia. Acta Obstet Gynecol Scand 1992;71: 145-7.[ISI][Medline]
11. Vink GJ, Moodley J, Philpott RH. Effect of dihydralazine on the fetus in the treatment of maternal hypertension. Obstet Gynecol 1980;55: 519-22.[ISI][Medline]
12. Vink GJ, Moodley J. The effect of low-dose dihydrallazine on the fetus in the emergency treatment of hypertension in pregnancy. S Afr Med J 1982;62: 475-7.[ISI][Medline]
13. Waisman GD, Mayorga LM, Camera MI, Vignolo CA, Martinotti A. Magnesium plus nifedipine: potentiation of hypotensive effect in preeclampsia? Am J Obstet Gynecol 1988;159: 308-9.[ISI][Medline]
14. Magee LA, Ornstein MP, von Dadelszen P. Fortnightly review: management of hypertension in pregnancy. BMJ 1999;318: 1332-6.[Free Full Text]
15. Cutler JA. Calcium-channel blockers for hypertension-uncertainty continues. N Engl J Med 1998;338: 679-81.[Free Full Text]
16. Liu L, Wang JG, Gong L, Liu G, Staessen JA. Comparison of active treatment and placebo in older Chinese patients with isolated systolic hypertension. Systolic Hypertension in China (Syst-China) Collaborative Group. J Hypertens 1998;16: 1823-9.[CrossRef][ISI][Medline]
17. Staessen JA, Fagard R, Thijs L, Celis H, Arabidze GG, Birkenhager WH, et al. Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. The Systolic Hypertension in Europe (Syst-Eur) Trial Investigators. Lancet 1997;350: 757-64.[CrossRef][ISI][Medline]
18. Ben Ami M, Giladi Y, Shalev E. The combination of magnesium sulphate and nifedipine: a cause of neuromuscular blockade. Br J Obstet Gynaecol 1994;101: 262-3.[ISI][Medline]
19. Snyder SW, Cardwell MS. Neuromuscular blockade with magnesium-sulfate and nifedipine. Am J Obstet Gynecol 1989;161: 35-6.[ISI][Medline]
20. Brown MA, McCowan LM, North RA, Walters BN. Withdrawal of nifedipine capsules: jeopardizing the treatment of acute severe hypertension in pregnancy? Australasian Society for the Study of Hypertension in Pregnancy. Med J Aust 1997;166: 640-3.[ISI][Medline]
21. Stevens TP, Guillet R. Use of glucagon to treat neonatal low-output congestive heart failure after maternal labetalol therapy. J Pediatr 1995;127: 151-3.[ISI][Medline]
22. Egger M, Smith GD. Principles of and procedures for systematic reviews. In: Egger M, Smith GD, Altman DG, eds. Systematic reviews in health care: meta-analysis in context. London: BMJ Books, 2003: 23-42.
23. Clarke M, Oxman AD, eds. Cochrane reviewer's handbook 4.2.0. In: Cochrane Library, Issue 2, 2003. www.cochrane.de/cochrane/hbook.htm (accessed 24 Sep 2003).
24. Organization of a systematic review for the Cochrane Neonatal Review Group: guidelines for reviewers and editors. Cochrane Collaboration, 2002. hiru.mcmaster.ca/cochrane/centres/canadian/neonatal/checklist.pdf (accessed 16 Sep 2003).
25. Bolte AC, van Eyck J, Strack van Schijndel RJ, van Geijn HP, Dekker GA. The haemodynamic effects of ketanserin versus dihydralazine in severe early-onset hypertension in pregnancy. Br J Obstet Gynaecol 1998;105: 723-31.[ISI][Medline]
26. Bolte AC, van Eyck J, Kanhai HH, Bruinse HW, van Geijn HP, Dekker GA. Ketanserin versus dihydralazine in the management of severe early-onset preeclampsia: maternal outcome. Am J Obstet Gynecol 1999;180: 371-7.[ISI][Medline]
27. Harper A, Murnaghan GA. Maternal and fetal haemodynamics in hypertensive pregnancies during maternal treatment with intravenous hydralazine or labetalol. Br J Obstet Gynaecol 1991;98: 453-9.[ISI][Medline]
28. Kwawukume EY, Ghosh TS. Or